Literature DB >> 6952258

Role of endothelial cells in relaxation of isolated arteries by bradykinin.

P D Cherry, R F Furchgott, J V Zawadzki, D Jothianandan.   

Abstract

Bradykinin elicits relaxation of isolated transverse rings of canine coronary, celiac, superior mesenteric, renal, splenic, pulmonary, gastric, and femoral arteries. After endothelial cells of the vessel wall are removed by rubbing of the intimal surface, canine arteries fail to relax upon addition of bradykinin. The endothelium-dependent relaxation of canine arteries remains intact after treatment with cyclooxygenase inhibitors (indomethacin and flurbiprofen), and this argues against mediation by prostaglandins. When they are stimulated with bradykinin, endothelial cells of canine arteries appear to release a substance mediating vascular smooth muscle relaxation. In contrast, preparations of arteries of cats (superior mesenteric) and rabbits (superior mesenteric and celiac) may be rubbed on the intimal surface without a consistent loss of sensitivity to the relaxing effects of bradykinin. In addition, relaxation of the cat and rabbit arteries is completely blocked by cyclooxygenase inhibitors. Preliminary studies indicate that bradykinin relaxes human arteries in an endothelium-dependent manner and that this effect is not mediated by prostaglandins. We have previously reported that arteries of all species tested require the presence of endothelial cells for relaxation in response to acetylcholine and we have also demonstrated, using the rabbit aorta, that this effect is mediated by the release of an uncharacterized substance from these cells that relaxes vascular smooth muscle. We conclude that bradykinin relaxes canine and human arteries via a similar mechanism but that it relaxes cat and rabbit arteries by stimulating release of prostaglandins from as yet undefined cell types.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6952258      PMCID: PMC346132          DOI: 10.1073/pnas.79.6.2106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  9 in total

1.  Purification of bradykinin by ion-exchange chromatography.

Authors:  S O ANDRADE; M R SILVA
Journal:  Biochem J       Date:  1956-12       Impact factor: 3.857

2.  The actions of bradykinin and eledoisin in the canine isolated kidney: relationships to prostaglandins.

Authors:  J C McGiff; H D Itskovitz; N A Terragno
Journal:  Clin Sci Mol Med       Date:  1975-08

3.  Prostaglandin synthesis by bovine mesenteric arteries and veins.

Authors:  D A Terragno; K Crowshaw; N A Terragno; J C McGiff
Journal:  Circ Res       Date:  1975-06       Impact factor: 17.367

4.  The importance of phospholipase-A2 in prostaglandin biosynthesis.

Authors:  R J Flower; G J Blackwell
Journal:  Biochem Pharmacol       Date:  1976-02-01       Impact factor: 5.858

Review 5.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

6.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

7.  Role of the intima in cholinergic and purinergic relaxation of isolated canine femoral arteries.

Authors:  J G De Mey; P M Vanhoutte
Journal:  J Physiol       Date:  1981-07       Impact factor: 5.182

8.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

9.  Actions of bradykinin on isolated cerebral and peripheral arteries.

Authors:  N Toda
Journal:  Am J Physiol       Date:  1977-03
  9 in total
  74 in total

1.  The role of myocardial perfusion imaging in vascular endothelial dysfunction.

Authors:  V Dilsizian
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Acute effects of bradykinin on cerebral microvascular permeability in the anaesthetized rat.

Authors:  M H Sarker; D E Hu; P A Fraser
Journal:  J Physiol       Date:  2000-10-01       Impact factor: 5.182

3.  Endothelial AT(2)-receptors: chicken or egg?

Authors:  Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

4.  Effects of prostaglandin I2 synthesized in the endothelium and in the smooth muscle on mechanical properties of the canine thoracic aorta.

Authors:  M Domae; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

5.  Nitric oxide derived from human umbilical vein endothelial cells inhibits transendothelial migration of neutrophils.

Authors:  Satoshi Oka; Masataka Sasada; Kokichi Yamamoto; Masaharu Nohgawa; Atsushi Takahashi; Kouhei Yamashita; Hiroko Yamada; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

6.  Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure.

Authors:  J D Conger; J B Robinette; R W Schrier
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

7.  Impairment of endothelium-dependent relaxation: an early marker for atherosclerosis in the rabbit.

Authors:  L Jayakody; T Kappagoda; M P Senaratne; A B Thomson
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

Review 8.  Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters.

Authors:  L J Ignarro
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

9.  The effect of endothelins on nitric oxide and prostacyclin production from human umbilical vein, porcine aorta and bovine carotid artery endothelial cells in culture.

Authors:  D G White; J W Mundin; M J Sumner; I S Watts
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

Review 10.  Shaping future strategies for the pharmacological control of tumor cell metastases.

Authors:  R G Greig; D L Trainer
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.